Cellectricon Overview
- Founded
-
2000
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Cellectricon General Information
Description
Provider of drug discovery services intended to offer compounds to the clinic and provide early-stage drug discovery. The company's service is ideal for compound profiling in primary cells and native tissue, which creates disease models and assays for functional and morphological screening, enabling researchers to identify phenotypic effects in relevant biological models early enough in a project's lifecycle.
Contact Information
Website
www.cellectricon.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Drug Discovery
Primary Office
- Neongatan 4B
- 431 53 Molndal
- Sweden
+46 031-760 00 00
Cellectricon Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 01-Apr-2022 | 000.00 | Completed | Generating Revenue | ||
| 5. Secondary Transaction - Private | 000.00 | Completed | Generating Revenue | |||
| 4. Grant | 30-Sep-2006 | 00000 | 000.00 | Completed | Generating Revenue | |
| 3. Early Stage VC (Series B) | 26-May-2004 | 00.000 | 000.00 | Completed | Startup | |
| 2. Early Stage VC | 24-Jun-2002 | $4.67M | $6.48M | Completed | Startup | |
| 1. Seed Round | 13-Dec-2000 | $1.8M | $1.8M | Completed | Startup |
Cellectricon Patents
Cellectricon Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3174128-A1 | Multi-well plates for creation of high-density arrays of compartmentalized cell cultures for usage in high capacity applications | Pending | 08-Apr-2020 | 0000000000 | |
| EP-3892713-A1 | Multi-well plates for creation of high-density arrays of compartmentalized cell cultures for usage in high capacity applications | Pending | 08-Apr-2020 | 0000000000 | 0 |
| US-20230127798-A1 | Multi-well plates for creation of high-density arrays of compartmentalized cell cultures for usage in high capacity applications | Pending | 08-Apr-2020 | 0000000000 | |
| CA-3114509-A1 | Compartmentalized cell cultures for usage in high capacity applications | Pending | 09-Oct-2018 | 000000000 | |
| EP-3864134-A1 | Compartmentalized cell cultures for usage in high capacity applications | Pending | 09-Oct-2018 | C12M23/20 |
Cellectricon Executive Team (7)
Cellectricon Board Members (10)
| Name | Representing | Role | Since |
|---|---|---|---|
| Axel Broms | Self | Board Member | 000 0000 |
| Camilla Svensson Ph.D | Self | Board Member | 000 0000 |
| David Burns | Self | Board Member | 000 0000 |
| Franziska Denk Ph.D | Self | Board Member | 000 0000 |
| Henrik Zetterberg Ph.D | Self | Board Member | 000 0000 |
Cellectricon Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Cellectricon Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Dunross & Co | PE/Buyout | Minority | 000 0000 | 000000 0 |